NASDAQ:AMPH Amphastar Pharmaceuticals Q2 2026 Earnings Report $19.74 +0.11 (+0.53%) As of 10:57 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Amphastar Pharmaceuticals EPS ResultsActual EPSN/AConsensus EPS $0.63Beat/MissN/AOne Year Ago EPSN/AAmphastar Pharmaceuticals Revenue ResultsActual RevenueN/AExpected Revenue$179.71 millionBeat/MissN/AYoY Revenue GrowthN/AAmphastar Pharmaceuticals Announcement DetailsQuarterQ2 2026Date8/6/2026TimeAfter Market ClosesConference Call DateThursday, August 6, 2026Conference Call Time5:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Amphastar Pharmaceuticals Earnings Headlines1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing ChallengesJuly 10, 2026 | uk.finance.yahoo.comAmphastar Receives Warning Letter from FDA for Facility's Manufacturing PracticesJuly 8, 2026 | marketwatch.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.July 21 at 1:00 AM | InvestorPlace (Ad)Amphastar unit gets FDA warning letter over manufacturing violationsJuly 8, 2026 | seekingalpha.comBofA cuts ratings on four biopharma stocks over valuation and catalyst concernsJune 29, 2026 | ca.finance.yahoo.comHealth Care Flat as Traders Rotate Into Laggards From Tech - Health Care RoundupJune 17, 2026 | marketwatch.comSee More Amphastar Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Amphastar Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amphastar Pharmaceuticals and other key companies, straight to your email. Email Address About Amphastar PharmaceuticalsAmphastar Pharmaceuticals (NASDAQ:AMPH) is a specialty pharmaceutical company headquartered in Rancho Cucamonga, California. Founded in 2004, Amphastar focuses on the development, manufacturing and commercialization of injectable and inhalation products. The company’s manufacturing facilities in California produce both generic and proprietary formulations designed to address urgent and chronic medical conditions. Amphastar’s portfolio includes a range of injectable generics such as epinephrine, naloxone and lidocaine, serving hospital, emergency medical and retail pharmacy channels. The company also markets proprietary respiratory therapies, including over-the-counter inhaled products. Amphastar leverages its in-house drug delivery technologies to support both its own product lines and contract manufacturing services for third-party partners. In addition to marketed products, Amphastar maintains a pipeline of new drug candidates and device enhancements, including next-generation inhalation systems and branded formulations. The company’s research and development efforts are centered on improving patient access to essential medications while advancing delivery platforms that enhance convenience and dosing precision. Amphastar primarily serves the U.S. pharmaceutical market, with select international distribution partnerships. Leadership is anchored by Chief Executive Officer Enno Walther, who oversees strategic growth initiatives and manufacturing operations. The company is governed by a board of directors with experience in pharmaceutical development, regulatory affairs and commercial strategy.View Amphastar Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Is Domino's Stock Serving Up a Buying Opportunity?Meta Platforms Turns AI Power Scarcity Into a $10 Billion Cloud BetAmazon’s AI Spending Is About to Face Its Most Important AWS Test YetMarketBeat Week in Review – 07/13- 07/17Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to BenefitBank Earnings Are Roaring, But Wall Street Isn't Ready to CelebrateThe Market Sold Alcoa After Earnings—But It May Be Missing the Real Story Upcoming Earnings Tesla (7/22/2026)Freeport-McMoRan (7/22/2026)Alphabet (7/22/2026)International Business Machines (7/22/2026)ServiceNow (7/22/2026)AT&T (7/22/2026)TE Connectivity (7/22/2026)Texas Instruments (7/22/2026)United Rentals (7/22/2026)Philip Morris International (7/22/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
